Loading...
No difference in persistence to treatment with atazanavir or darunavir in HIV patients in a real-world setting
INTRODUCTION: There is a lack of data comparing the protease inhibitors (PIs) atazanavir (ATV) and darunavir (DRV) in a real-world setting. This study compared persistence (time to switch/discontinuation) to therapy between ATV-treated and DRV-treated patients with human immunodeficiency virus (HIV)...
Na minha lista:
| Udgivet i: | J Int AIDS Soc |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
International AIDS Society
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4224837/ https://ncbi.nlm.nih.gov/pubmed/25394047 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7448/IAS.17.4.19538 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|